Mr. Ross Orr reports

BACTECH CLOSES FIRST TRANCHE OF UNIT FINANCING

Bactech Environmental Corp. has closed the first tranche of a non-brokered private placement.

Bactech has price protection for this offering of 20 million units at a price of five cents per unit for total gross proceeds up to $1-million. Each unit consists of one common share of the company and one common share purchase warrant. Each warrant shall entitle the holder to purchase one common share at a price of 10 cents for up to 24 months from closing. In the event the common shares trade at or above 20 cents for 10 consecutive trading days, as indicated on the Canadian Securities Exchange, the corporation shall give notice by way of a news release that the warrants will expire 20 trading days thereafter.

Today, the company closed the first tranche of the private placement with 6,634,000 units for gross proceeds of $331,700. The company has issued 6,634,000 common shares and 6,634,000 share purchase warrants.

Further to the company's earlier announcement, a second closing for an additional $200,000 will occur within the next two weeks.

In connection with this private placement, the company paid finders' fees of an aggregate $4,400 in cash and 96,000 broker warrants. Each broker warrant shall entitle the holder to purchase one common share at a price of 10 cents up to 24 months from closing.

In the event the common shares trade at or above 20 cents for 10 consecutive trading days, as indicated on the CSE, the corporation shall have give notice by way of a news release that the warrants will expire 20 trading days thereafter.

Insiders of the company purchased 1,184,000 units for gross proceeds of $59,200.

About Bactech Environmental Corp.

Bactech is a company that specializes in environmental technology. It uses a process called bioleaching to recover metals like gold, silver, cobalt, nickel and copper, while also safely removing harmful contaminants like arsenic. This process is eco friendly and uses naturally occurring bacteria that are safe for both humans and the environment. By using its proprietary method of bioleaching, Bactech can neutralize toxic concentrates and tailings, while also creating profitable opportunities. The company is publicly traded on several stock exchanges, including the CSE, OTCQB and Frankfurt Stock Exchange.

We seek Safe Harbor.